Inmune Bio Files 8-K: Other Events & Financials
Ticker: INMB · Form: 8-K · Filed: Oct 11, 2024 · CIK: 1711754
| Field | Detail |
|---|---|
| Company | Inmune Bio, Inc. (INMB) |
| Form Type | 8-K |
| Filed Date | Oct 11, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financials, disclosure
Related Tickers: INMB
TL;DR
INMB filed an 8-K for other events and financials - check for updates.
AI Summary
On October 11, 2024, Inmune Bio, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and operational events. Specific details regarding the nature of these events or financial figures are not elaborated in the provided text.
Why It Matters
This filing signals to investors that Inmune Bio, Inc. has made significant disclosures or experienced material events that could impact the company's financial standing or operational direction.
Risk Assessment
Risk Level: medium — 8-K filings often contain material information, but the lack of specific details in this excerpt necessitates a medium risk assessment until the full content is reviewed.
Key Numbers
- 001-38793 — SEC File Number (Identifies the company's filing with the SEC.)
- 47-5205835 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Inmune Bio, Inc. (company) — Registrant
- October 11, 2024 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- Boca Raton, Florida (location) — Principal Executive Offices
FAQ
What specific "Other Events" are being reported by Inmune Bio, Inc. in this 8-K filing?
The provided text does not specify the nature of the "Other Events" reported.
What "Financial Statements and Exhibits" are included with this 8-K filing?
The provided text indicates that financial statements and exhibits are part of the filing, but does not list their specific contents.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on October 11, 2024.
What is Inmune Bio, Inc.'s state of incorporation?
Inmune Bio, Inc. is incorporated in Nevada.
What is the principal executive office address for Inmune Bio, Inc.?
The principal executive office is located at 225 NE Mizner Blvd., Suite 640, Boca Raton, Florida 33432.
Filing Stats: 450 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-10-11 16:00:24
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per shares INMB The NASDAQ Stock Ma
Filing Documents
- ea0217356-8k_inmune.htm (8-K) — 23KB
- ea021735602ex99-1_inmune.htm (EX-99.1) — 7KB
- ex99-1_001.jpg (GRAPHIC) — 5KB
- 0001213900-24-087245.txt ( ) — 211KB
- inmb-20241011.xsd (EX-101.SCH) — 3KB
- inmb-20241011_lab.xml (EX-101.LAB) — 33KB
- inmb-20241011_pre.xml (EX-101.PRE) — 22KB
- ea0217356-8k_inmune_htm.xml (XML) — 4KB
01. Other Events
Item 8.01. Other Events. On October 11, 2024, INmune Bio Inc. (the "Company"), issued a press release announcing that the Company's management will participate in the upcoming Maxim Healthcare Virtual Summit, to be held October 15-17, 2024. A copy of the Company's press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
01 Financial statements and Exhibits
Item 9.01 Financial statements and Exhibits (d) Exhibits. 99.1 Press Release dated October 11, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INMUNE BIO INC. Date: October 11, 2024 By: /s/ David Moss David Moss Chief Financial Officer 2